Immunomedics Inc (IMMU.O)

IMMU.O on Consolidated Issue listed on NASDAQ Global Market

3.98USD
28 Apr 2015
Change (% chg)

$-0.02 (-0.50%)
Prev Close
$4.00
Open
$4.01
Day's High
$4.06
Day's Low
$3.86
Volume
356,387
Avg. Vol
1,063,142
52-wk High
$5.48
52-wk Low
$3.04

IMMU.O

Chart for IMMU.O

About

Immunomedics, Inc. is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders and other serious diseases. Using its technologies, the Company has built a pipeline of nine clinical-stage product candidates. Its advanced product candidate... (more)

Overall

Beta: 0.74
Market Cap(Mil.): $373.55
Shares Outstanding(Mil.): 93.39
Dividend: --
Yield (%): --

Financials

  IMMU.O Industry Sector
P/E (TTM): -- 160.64 40.89
EPS (TTM): -0.50 -- --
ROI: -187.82 -0.73 16.14
ROE: -199.76 -2.64 16.96
Search Stocks

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $34.49 -0.10
Roche Holding Ltd. (ROG.VX) CHF273.30 -5.50
Bayer AG (BAYGn.DE) €134.40 -3.95
Bayer AG (BAYE.F) -- --
AstraZeneca plc (AZN.L) 4,548.00p -157.50
GlaxoSmithKline plc (GSK.L) 1,538.00p -24.00
Eli Lilly and Co (LLY.N) $71.01 +0.12
Bristol-Myers Squibb Co (BMY.N) $64.42 -0.74
Bristol-Myers Squibb Co (BMYMP.PK) $1,110.23 --
Amgen, Inc. (AMGN.OQ) $163.43 +1.05

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks